Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP206395.RAtLePhyNL_8bqg_epRc3ouTH3tWJkualPr2yGZ3DY-Zs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP206395.RAtLePhyNL_8bqg_epRc3ouTH3tWJkualPr2yGZ3DY-Zs130_assertion type Assertion NP206395.RAtLePhyNL_8bqg_epRc3ouTH3tWJkualPr2yGZ3DY-Zs130_head.
- NP206395.RAtLePhyNL_8bqg_epRc3ouTH3tWJkualPr2yGZ3DY-Zs130_assertion wasGeneratedBy ECO_0000203 NP206395.RAtLePhyNL_8bqg_epRc3ouTH3tWJkualPr2yGZ3DY-Zs130_provenance.
- NP206395.RAtLePhyNL_8bqg_epRc3ouTH3tWJkualPr2yGZ3DY-Zs130_assertion wasDerivedFrom befree-20140225 NP206395.RAtLePhyNL_8bqg_epRc3ouTH3tWJkualPr2yGZ3DY-Zs130_provenance.
- NP206395.RAtLePhyNL_8bqg_epRc3ouTH3tWJkualPr2yGZ3DY-Zs130_assertion SIO_000772 23741342 NP206395.RAtLePhyNL_8bqg_epRc3ouTH3tWJkualPr2yGZ3DY-Zs130_provenance.
- NP206395.RAtLePhyNL_8bqg_epRc3ouTH3tWJkualPr2yGZ3DY-Zs130_assertion evidence source_evidence_literature NP206395.RAtLePhyNL_8bqg_epRc3ouTH3tWJkualPr2yGZ3DY-Zs130_provenance.
- NP206395.RAtLePhyNL_8bqg_epRc3ouTH3tWJkualPr2yGZ3DY-Zs130_assertion description "[Inhibitors of FASN, such as orlistat, reportedly show antitumor effects against cancers that over-express FASN, making FASN a promising therapeutic target.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP206395.RAtLePhyNL_8bqg_epRc3ouTH3tWJkualPr2yGZ3DY-Zs130_provenance.